SC company to play role in vaccine distribution see more
A South Carolina pharmaceutical company will play a huge role in getting a COVID-19 vaccine to the American people.
Columbia-based Ritedose Corporation announced Thursday it’s been named a partner in Operation Warp Speed and will be responsible for filling and packaging millions of vaccines.
ApiJect, a medical technology company that received $138 million from the federal government to produce the first 100 million COVID-19 vaccines, patented the vial in which the vaccine will be distributed. They needed Ritedose to produce and manufacture those vials with their blow-fill-seal technology.
Ritedose CEO Jody Chastain says more COVID-19 vaccines will be packaged and filled in Columbia than any other place in the country.
“It’s tremendously rewarding,” Chastain explained.
He and his employees did the near impossible, getting two 150,000 square-foot warehouses ready to package and fill the vaccines in only a few months.
“Typically, that would take anywhere from 18-24 months, but within five months, we were able to outfit the facility to be able to handle the vaccine,” said Chastain.
Ritedose has upped its staff by more than 10% to help handle the demand.
“The potential for the workforce here in Columbia is huge, as well as putting Columbia on the map in the response to COVID,” Chastain noted.
The company’s nearly 400 employees also learned Thursday the role they will play in distributing the vaccine.
“It’s been hush-hush around the facility,” said Chastain. “People know that we’ve been doing work around the facility to be able to handle a new product, but they were unaware of what the new product is. Making this announcement to the employees today was very exciting because they’ve been able to see a tremendous amount of pride that’s been able to go into the workforce to be able to handle the vaccine.”
As soon as a vaccine candidate receives FDA approval, Ritedose will work with the company to make sure the vaccine is compatible with their plastic packaging.
“We’re much more efficient,” said Chastain. “We can produce a higher volume in a shorter time period.”
Once the vaccine is rolled out, front line workers, like Prisma Health Baptist Parkridge doctor Jennifer Risinger, will be the first in line.
“I’m very encouraged that we’re looking at months instead of years,” said Risinger.
She says she and her colleagues are eager to get the vaccine.
“It does give us a sense of relief and confidence that we’ll be able to deliver the care that people here in the Midlands deserve,” she noted. “I think we should all be very proud that we have a local company who is this involved in bringing this to the national spotlight as soon as possible.”
Ritedose says it’s likely the first vaccines distributed in South Carolina will have been packaged and filled in Columbia.
Operation Warp Speed has a goal to produce and deliver 300 million safe and effective doses of the COVID-19 vaccines, with the first doses expected to be ready by January 2021.
Nephron prepping to fill COVID vaccines in state see more
LEXINGTON COUNTY, SC (WSPA) — With a potential COVID-19 vaccine looming, one South Carolina company said they’ll be able to fill vaccines next year.
According to Nephron Pharmaceuticals CEO and Founder Lou Kennedy, the company is in the midst of a $215 million expansion. They are adding new office and new warehouse space. The investment will also create more than 380 jobs the company said.
The expansion also includes vaccine production space. Kennedy said once completed, they’ll be able to fill COVID-19 vaccines at their facility.
“We’re actively looking for the right partner that will produce and we’ll fill the vaccine. We’re speaking with people throughout the federal government and Department of Defense to find the right partner,” Kennedy said.
Tuesday, the company held a beam raising ceremony to celebrate their expansion. Kennedy said she expects to have the vaccine production space completed by March 2021.
As of Tuesday afternoon, the FDA has not approved a COVID-19 vaccine for distribution. However, preliminary reports on vaccines from Moderna Inc. and Pfizer Inc. show their vaccines have at least a 90% effectiveness rate.
Kennedy said they are anticipating a medical grade glass shortage because of the high demand for the vaccine. She said they have the ability to work around that. “Our option will be to put the vaccine in plastic. We have the technology and the capability.”
Under the South Carolina Department of Health and Environmental Control’s (SCDHEC) statewide vaccine plan, front line medical personnel and nursing home residents will be some of the first South Carolinians to get doses of an approved vaccine. They anticipate vaccine supply will be limited to start off, but Kennedy hopes they can help alleviate that.
She said, “We’re right in tandem with the research work and the clinical trials that are going on. We’re trying to time that perfectly for the vaccine filling side of it.”
Companies find ways to thrive despite pandemic see more
Seven months ago, John Carrington took a deep breath and pushed all his chips to the center of the table.
His Columbia company, ZVerse, was at a crossroads. Founded in 2013 as a 3D design and software solutions provider, the Shop Road outfit faced overwhelming demand for the protective face shield that had grown from an idea hatched to help local hospitals into orders multiplying into the millions.
“The first request we had was for 3,000 units, which we could solve, no problem,” Carrington said. “The next day it was 10,000, and the next day it was 50,000, and at that point we knew that 3D printing would not be able to keep up with that demand. … We had to place a bet.”
The wager involved shutting down for a few weeks to completely retool ZVerse’s production process to injection molding while scaling up from an 8,000-square-foot facility to a 30,000-square-foot one that could fill three tractor-trailers a day. Continue reading by clicking here...
Zverse a hit on Amazon see more
The country's largest producer of branded face shields has made its top-selling products available for purchase on Amazon.
Earlier this spring, digital manufacturing company ZVerse created a first-ever PPE product to be marketed and sold directly to consumers: The ZShield, an ultra-lightweight, neck-mounted face shield designed to provide a comfortable, wearable barrier that helps users shield their face, mouth and eyes from spray, splatter, and the direct transfer of respiratory droplets. ZVerse has since produced over four million face shields, and now, several of its products are available for purchase on Amazon, marking another milestone for the company. All products are made in the USA.
"At the height of the COVID-19 impact on the U.S., we recognized our unique ability to quickly produce and provide valuable PPE to our front-line healthcare heroes, while also creating jobs and stimulating the local economy," said John Carrington, founder and CEO of ZVerse. "We have since grown our PPE product pipeline to serve a number of industries. We owe a tremendous amount of gratitude to our partners and customers for helping us reach this milestone with Amazon."
Shoppers on Amazon now have access to four ZShield models, including the ZShield Health, the ZShield Flex, the ZShield Wrap and the ZShield Youth. ZShields can be purchased individually and in packs of two or five. Replacement shields for both the Flexand Wrap are also on sale in quantities of five or 10.
Based on industry and customer demand, ZVerse creates face shields that provide a threshold of hygiene for those seeking options for face coverings. ZShields allow for clear verbal and nonverbal communication and all-day comfort when masks or stationary sneeze guards are not practical, or when environments call for the use of both a shield and a face mask. The ZShield has completely disrupted the industry, bringing much-needed design innovation to the world of PPE and earning ZVerse a 2020 Innovation by Design Award from Fast Company. ZVerse is now producing hundreds of thousands of ZShields a day, which are all designed, sourced and made in the USA through an established domestic supply chain.
Nephron employees achieve Lean Six Sigma green belt certification see more
If there were ever a time for improved efficiency to help a fast-moving company, it would be now for Nephron Pharmaceuticals Corp.
With the West Columbia-based manufacturer of sterile respiratory medication churning out product at a record pace during the COVID-19 health crisis, owner and CEO Lou Kennedy is in search of every competitive advantage available.
“In spite of my Southern accent, I do move like a New Yorker, and this company goes at that pace,” she said. “It’s a testament to the team here that everybody’s running on high-test, premium unleaded, and keeping up.”
The most recent example came when nine Nephron employees achieved Lean Six Sigma green belt certification after completing courses at the University of South Carolina’s Darla Moore School of Business. Six Sigma or lean manufacturing, pioneered by the likes of Henry Ford and famously implemented by Toyota in the years following World War II, is a systematic method aimed at reducing waste and variation to improve production quality and efficiency.
Zverse honored in national competition see more
Columbia-based digital manufacturing company ZVerse has won a national design award for its ZShield Flex.
The ZShield, designed and manufactured by Columbia-based ZVerse, has won a national design award for innovation. (Photo/Provided)
The face shield, designed and produced by ZVerse, has been named an Innovation by Design Awards winner by business magazine Fast Company. The awards, in their ninth year, recognize creative, problem-solving innovations and have included winners such as Spotify, Google and Disney+.
The shields feature lightweight visors that clip around the wearer’s neck, making the shield comfortable for all-day wear. ZVerse’s computer assisted design platform creates custom, manufacturable 3D files that are returned to clients for production, enabling an invention to quicky go from idea to reality.
“We need innovative design more than ever, and the 2020 honorees have brought creativity, inventiveness, and humanity to address some of the world's most pressing problems, including the global pandemic, racial injustice, and economic inequality,” Stephanie Mehta, editor-in-chief of Fast Company, said in a news release. “Together these entries offer a glimpse into a future that is more inclusive, more accessible, and more just.”
The ZShield Flex won in the Workplace category and also received an honorable mention in the Best Design of North America category alongside companies such as Microsoft, Google and Logitech. A complete list of winners, finalists, and honorable mentions are featured online and in the October-November issue of Fast Company, on newsstands Oct. 20.
In March, ZVerse founder and CEO John Carrington adapted the company’s business model to accelerate the mass production of face shields in response to a health care community struggling to deal with the COVID-19 health crisis. The company tested more than a dozen designs before settling on the ZShield, focused initially on the needs of health care workers before being adapted in partnership with industrial designer Scott Henderson for everyday use.
“At the onset of the pandemic, we recognized our unique role in the world as great enablers of digital manufacturing, and we pivoted to become one of the largest producers of face shields to serve our country’s urgent need for PPE,” Carrington said in the release. “After launching with ZShield Health, we brought on Scott Henderson to reimagine the traditional face shield design and create a product that would be comfortable for a variety of work environments as well as everyday life. Going to market with such a novel design and seeing it in use by so many people and industries has been a humbling experience. We’re honored to be recognized by Fast Company for our work; it’s truly been a labor of love.”
To date, ZVerse has produced more than four million shields, nearly tripling its workforce. Notable users include television and film production companies, Disney, Chick-fil-A, Four Seasons Hotels and Resorts, and Walgreens, according to the release.
“When ZVerse originally contacted me about collaborating, I immediately realized how historic this moment was and felt an urgent need to help with the project,” Henderson said. “Prior to COVID-19, face shields weren't considered an essential accessory outside of the healthcare and medical science industry. After a century of little innovation in regard to face shield design, I am so proud of our team for applying out-of-the-box critical thinking to create this new option for PPE.”
DPX Technologies introduces new product line see more
DPX Technologies, a manufacturer of laboratory consumables for sample preparation, announces the development of a new product line for size exclusion chromatography. The technology is patent-pending and utilizes a novel INTip swelling method that supports a hands-off approach for size exclusion chromatography workflows. The automated INTip swelling process allows the gel resin bed to be prepped and ready for sample application in less than 20 minutes.
Size exclusion chromatography (SEC), also known as gel filtration, is a method by which molecules pass through SEC resin media and are separated by their size. The DPX methodology uses a group separation technique for desalting and buffer exchange where small molecules such as salts are separated from a group of larger molecules such as proteins. Desalting and buffer exchange are commonly used prior to affinity chromatography for antibody purification or polymerase chain reaction (PCR) cleanup. The new product line includes SEC pipette tips and automation accessories, offering a highly reproducible, automated solution for proteomics applications.
Antibody testing and PCR cleanup are highly conversed topics due to the COVID- 19 pandemic, and DPX is committed to developing products that simplify and automate complex sample preparation for biological matrices. “This new product, along with INTip filtration products for Tip-on-Tip solid phase extraction, will help laboratories that need high throughput methods for processing thousands of samples daily, ” said Dr. Matthew Fitts, lead molecular biologist at DPX Technologies.
DPX has been manufacturing pipette tips for sample preparation since 2007 and specializes in developing custom workflows for a diverse client base.
# # #
About DPX Technologies
DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis.
Partnership Reduces Barriers to Testing, Provides Top Quality to Customers see more
Compliments of MidlandsBiz
Partnership Reduces Barriers to Testing, Provides Top Quality to Customers
Nephron Pharmaceuticals Corporation, one of the fastest-growing pharmaceuticals companies in the country, announced a new collaboration with Methapharm.
As a part of this collaboration, Nephron will produce kits of methacholine chloride sterile inhalation solution in ready-to-administer concentrations for bronchoprovocation challenge testing, when diagnosing respiratory illnesses, such as asthma.
“Methapharm will be a fantastic partner,” said Nephron CEO Lou Kennedy. “Patients deserve access to the very best respiratory tests available, that’s what this collaboration will offer, and that’s why we are looking forward to working with Methapharm.”
Working together with Methapharm, Nephron will be able to supply stable room temperature solution kits, ensuring that testing facilities can continue to rely on the quality and reliability of Provocholine for their bronchoprovocation testing needs.
“Through this partnership with Nephron, Methapharm continues its mission to help reduce barriers to testing, provide the level of quality our customers expect, and contribute to better healthcare outcomes for our patients,” said Craig Baxter CEO of Methapharm. “We’ve been impressed by Nephron’s capabilities and professionalism.”
Provocholine® is the only FDA-approved methacholine chloride powder for use in humans. Methapharm, the manufacturer of Provocholine, has always tried to be responsive to needs of our testing partners. For example, in response to the revised ERS technical standard, Methapharm initiated a comprehensive nebulizer characterization study to support the recommendation of PD20 as a clinical endpoint. This was published in a technical bulletin earlier this year.
A West Columbia, S.C.-based company, Nephron develops and produces safe, affordable generic inhalation solutions and suspension products, including those used to treat severe respiratory distress symptoms associated with COVID-19. The company also operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. Nephron fills the needs of patients and health care professionals as they arise nationwide, and recently opened a CLIA-certified diagnostics lab.
Effort to focus on life sciences, other knowledge-based industries see more
In preparation for an anticipated economic rebound once the effects of the COVID-19 health crisis subside, the Richland County Economic Development Office (RCEDO) has teamed with a group of regional partners to develop an economic development action plan for promoting the growth of knowledge-based industries within the region.
RCEDO is also collaborating on the plan’s marketing components with those partners, which include Lexington County, the City of Columbia, the University of South Carolina, Midlands Technical College, the S.C. Research Authority (SCRA) and the Central SC Alliance.
The initiative focuses on five knowledge-based industry segments: information technology/data analytics, financial services, aerospace, medical devices and the biosciences. It is designed to build on existing assets in the region and capitalize on the growing base of research, innovation and industry partnerships at the University of South Carolina.
“I am exceptionally proud that the entire economic development community in our region has united to ensure that we can more effectively compete to expand the number of knowledge-based jobs,” said Paul Livingston, chair of Richland County Council. “This initiative will have a substantial economic impact on the whole region.”
The plan also contains a robust marketing component, and RCEDO will collaborate with its regional alliances to implement key strategies. The development office will coordinate with partners to position and promote the Columbia region as a technology and innovation hub.
“South Carolina is among the most successful states in the nation in building its manufacturing base, but the state has not been as successful in generating jobs in knowledge-based industries,” said Garry Powers, who is overseeing the project for the County as a member of the Economic Development staff.
“The Columbia metro area has the highest concentration of software-related employment in the state, and bioscience-related companies are expanding rapidly in the region,” said Jeff Ruble, RCEDO director. “Therefore, once we adapt our economic development and workforce programs so that we have an improved capacity to support companies in these targeted industries, the Midlands region is well positioned to substantially increase employment, both within our existing firms and within the new firms that we will attract to the region.”
As part of this initiative, Deloitte Consulting has analyzed the region’s capacity to grow employment in the targeted industry segments. Using this information, the company developed a detailed action plan that mitigates competitive weaknesses and builds on the region’s strengths.
To assess the Midlands’ competitive position, Deloitte measured the region’s capacity to support industry expansion compared with more than two dozen other metro areas that are hotbeds of knowledge industry growth.
Further, the initiative identifies opportunities to improve the region’s competitive position in a variety of areas, including:
- Enhancing education/training programs based on an analysis of industry needs
- Expanding programs that build the talent pipeline
- Ensuring there is sufficient infrastructure (e.g., wet labs, broadband, real estate) to support the targeted industries
- Restructuring state/local education and training incentives and other state/local incentives to ensure they are competitive nationally
The SCRA is an active partner in the project because of its mandate to promote the growth of the state’s innovation economy by accelerating technology-enabled growth in research, academia, entrepreneurship and industry. Deloitte’s action plan includes provisions for growing existing small firms and attracting new, innovative small firms within the targeted industry segments. The plan will especially focus on firms capable of building university partnerships.
The project is expected to provide substantial economic development benefits statewide, and the region has established strong, project-related working relationships with several entities. These include the S.C. Department of Commerce, the State Board for Technical and Comprehensive Education, the S.C. Council on Competitiveness and SCBIO, a statewide, not-for-profit, public–private economic development organization that actively promotes, builds, supports, expands and convenes the state’s life sciences industry.
ZVerse and Phoenix Specialty Manufacturing step up for South Carolina see more
Two South Carolina companies -- ZVerse and Phoenix Specialty Manufacturing -- jumped into action to meet the needs of the response to the coronavirus, manufacturing vital pieces of equipment at a time when they were urgently needed and unlikely to be easily available for import.
In doing so, they played key roles as the country rushed to provide the medical supplies needed to protect the lives of the sick and their caregivers.
In Columbia, ZVerse began March as a company that helped manufacturers by creating more effective computer files for their production processes. It had the capability to do some 3D printing but did not usually do manufacturing.
Nephron gets nod from FDA see more
West-Columbia headquartered-Nephron Pharmaceutical Corp.’s fight against the COVID-19 pandemic has received an additional weapon.
The Food and Drug Administration approved the company’s request to add a production line used in the manufacturing of bronchodilator albuterol today, Nephron CEO Lou Kennedy told the Columbia Regional Business Report.
“This news came in 20 minutes ago,” Kennedy said Monday morning. “People are cheering. It’s like The Price is Right or something.”
Kennedy said she expects to hear whether a second production line has been approved later this week.
Last month, Kennedy petitioned the FDA to add up to six production lines moved to Columbia from the company’s previous Florida headquarters in 2019. Kennedy said the additional lines could help the sterile respiratory medication manufacturer keep up with unprecedented demand.
Kennedy said March saw a 141% increase in the doses of inhalation solutions Nephron typically produces a month.
“We went from a regular month of about 80 million shipped to 193 million shipped in March. That’s just for the respiratory side,” she said. “For our sterile injectable medications that we make for all the hospitals in America that have drug shortage needs, that was up by like 22%. We’re seeing the same exact trend in April.”
Kennedy praised the FDA for its quick response, saying the federal agency granted Nephron a CBE-30, “which means Change Being Effected. That’s giving you a goal date of 30 days or less to review your material and be able to say yes or no,” she said.
“That’s really something. You’ve just got to know and feel good as a patient or a potential patient in America that the FDA has been working with me on the phone almost every day, or by email, trying to get this through expeditiously so that we can crank up a few more lines.
“As much as we can make, we’re selling. I don’t want to get behind. So if we can get these other lines approved pretty quickly, then we’ll be able to pump out — if I get four lines, at least another 50 million a month.”
Also helping meet demand, Kennedy said, are the efforts of the S.C. Ports Authority.
Last Thursday, four gigantic containers of automated packaging equipment arrived at Nephron headquarters from Switzerland. Today, the company is expecting air delivery of critical supplies from Italy, one of the countries hardest-hit by the COVID-19 pandemic.
“You know how difficult that was to pull off?” Kennedy said.
Kennedy developed a working relationship with the port as she moved hundreds of millions of dollars in equipment from Florida to West Columbia when Nephron relocated to South Carolina in 2014. During her time as chair of the S.C. Chamber of Commerce from 2018-19, Kennedy came to know S.C. Ports CEO Jim Newsome and COO Barbara Melvin well.
Expecting last week’s shipment of automated equipment to help Nephron workers quickly label, package and ship products, Kennedy called Melvin.
“I reached out to see what the situation was going to be like in getting these pieces of equipment,” she said. “That equipment, which was four giant containers, arrived to the dot at 9 a.m. (Thursday) morning all because of two great South Carolina partners — UPS and its hub that’s located one exit from me, and the Ports Authority.
“All of these drugs that are packaged will go to benefit speedier to-market products for patients with COVID-19. … This is front-line equipment that we need to get our products to market quicker.”
Nephron is also gearing up to begin releasing 100-mL saline bags for administration of sodium chlorine. The minibags, made scarce after the 2017 hurricane season hit manufacturer Baxter Healthcare hard, are once again in short supply, Kennedy said.
“We are very happy to say that we’ve been producing 100-mL saline for the last two weeks in anticipation for this going on shortage,” said Kennedy, who said the bags would be released this past Friday.
While Nephron has ramped up production in response to previous respiratory illnesses such as SARS and H1N1, Kennedy said the COVID-19 crisis is unlike anything she’s ever seen. Nephron began making its own hand sanitizer last month, distributing 50 liters to the William Jennings Bryan Dorn Veteran Affairs Center.
“I had absolutely no idea we’d reach these levels. I couldn’t even imagine, can’t even imagine, still am trying to process,” Kennedy said. “One particular day, two or three weeks ago, one hospital system in New York ordered 3,000 nebulizers from us. A typical thing might be 50, no more than 100. They ordered 3,000.”
S.C. Ports and other transportation partners have helped Nephron fill the exploding demand, Kennedy said, while Nephron workers are proud to be playing a role in combating the virus.
“I couldn’t even begin to compare ourselves with what they’re doing at hospitals, but there is a true sense of patriotism,” she said. “People are coming to work optimistic in the fact that they’re helping, in their own small way, American patients.”
Dr. Carol Moore steps down as Columbia College president see more
Dr. Carol A. Moore announced her decision to step down as president of Columbia College after four years in the top leadership role. During her tenure, Dr. Moore helped Columbia College strengthen its mission of providing a strong liberal arts education and professional programs emphasizing service, social justice, and leadership development.
“The Columbia College family thanks President Moore for her tireless effort to make our school a special place for so many. She has taken on re-positioning Columbia College with leadership and strength,” Board of Trustees Chair Toby Goodlett said. “Since her arrival in September 2016, Dr. Moore has been invaluable to our mission. We respect her decision to step away at this time to care for her family and her health and we want to express our appreciation for her unwavering dedication to our school and mission,” Goodlett said.
The extraordinary planning necessary for a smooth transition to becoming a coeducational college, exacerbated by the challenges facing senior management to provide a comprehensive response to COVID 19, convinced the Board of Trustees to consider a familiar voice to lead. Former President, Dr. Peter Mitchell will serve as the interim President, effective immediately while the board starts a search for a permanent president.
As former President of Columbia College from 1988-97, Dr. Mitchell has a passion for the school and an understanding of and appreciation for the leadership role the College plays in South Carolina. During his tenure the Women’s Leadership Institute was established, the Johnnie Cordell Breed Leadership Center was built and Mitchell helped secure funding for the Barbara Bush Center for Science & Technology. For the past 13 years, Dr. Mitchell has served as a consultant to college and university trustees and presidents in the areas of strategic planning, enrollment management, and fundraising.
“Dr. Mitchell worked with Dr. Moore for four years and they have remained friends for decades. We have no doubt this transition will be seamless and the students and staff will be thrilled to have Dr. Mitchell’s excitement and energy on campus,” Goodlett said.
ABOUT COLUMBIA COLLEGE
Columbia College was founded in 1854 as Columbia Female College by the Methodist Conference of South Carolina. The College, located on Plain Street, now Hampton, in Columbia, SC, opened to students in October 1859. Columbia College continues to serve as an institution for higher education with approximately 1,200 male and female students in both undergraduate and graduate courses.
DPX unveils new brand, website see more
Columbia, SC – DPX Technologies, a manufacturer of laboratory consumable products, announces the launch of a new brand image. DPX has been manufacturing pipette tips for sample preparation since 2007. Their patented technologies are available across the U.S., and DPX plans to increase sales internationally.
The rebrand includes a new company logo, website and other marketing collateral. DPX also updated the product lines with a trademark for the name INTip™. Product lines include INTip™ Solid Phase Extraction and INTip™ Filtration. This strategic brand update aligns product segments within different industries and highlights pipette tip technology for sample preparation.
The future of DPX lies in the proteomics and genomics industries. Dr. Brewer sees a big future with INTip products for protein purification and DNA purification. “INTip compliments the existing core technology and delivers the new brand expansion for pipette tip products in market segments where automated sample preparation is highly sought after,” said Dr. Brewer, founder and CEO of DPX Technologies. “Pipette tips are easy to use and easy to automate, which will increase efficiency, robustness and reproducibility for protein purification and DNA purification.”
DPX products are currently sold across the U.S., Canada and in Brazil. “We are starting to pick up leads in Europe, Australia and China. We are excited about expanding our product offerings internationally,” said Bill Kemnitzer, PhD., Director of Sales and Business Development.
# # #
About DPX Technologies
DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis. Visit them at https://dpxtechnologies.com/.
University of South Carolina Opens Innovation Think Tank Lab in Partnership with Siemens HealthineersSiemens Healthineers and USC have forged a new partnership see more
The University of South Carolina has opened its Innovation Think Tank (ITT) Lab in downtown Columbia in collaboration with Siemens Healthineers. The space will be an innovation hub where participants including researchers, faculty members, and students can think outside the box to solve issues in healthcare, artificial intelligence, robotics, and information technology. The ITT Lab at South Carolina is the first Innovation Think Tank Lab affiliated with a U.S. university, as part of Siemens Healthineers' global network of Innovation Think Tank Labs led by adjunct professor Sultan Haider.
"Centers like this are so important because they bring technology and use it to create something new and do things differently," said Elizabeth Regan, the chair of Integrated Information Technology at the College of Engineering and Computing. "That involves opening your mind, moving yourself out of your comfort zone, innovative thinking, and collaborating."
Computer science professor Neset Hikmet, who oversaw the lab's creation, said his vision for the lab is to host workshops with participants from diverse academic backgrounds and to provide them with mentorship and resources to solve pressing issues in healthcare and beyond. "These are all opportunities that have participants getting out of their boundaries, meeting different people, and experiencing different cultures and ways of doing things," Hikmet said.
Hossein Haj-Hariri, dean of the College of Engineering and Computing, noted the importance of the university's growing partnership with Siemens. "The focus of Siemens Healthineers is very much aligned with that of modern curricula, which stress design thinking in addition to coverage of the fundamentals," Haj-Hariri said. "Furthermore, the innovation process underpinning Healthineers and ITT provides a natural platform for imparting to the participants the soft skills necessary for success in the 21st century."
Dilek Akgun, director of operations at the ITT Lab, said that this new facility will promote creative thinking in the future. "The ITT Lab will allow us to bring people together from a variety of disciplines to share their unique perspectives, which will stimulate innovation and help great ideas become reality," Akgun said.
Thanks to the UofSC ITT Lab's affiliation with Siemens Healthineers' global ITT infrastructure worldwide, the participants will be able to share knowhow with other ITT members and participate at its various locations in Germany, the U.K., China, Turkey, India, and the U.S. This global network will allow participants to collaborate with other innovators worldwide.
Siemens Healthineers' ITT Lab founder and director Haider, who is also now affiliated with the College of Engineering and Computing as an adjunct professor to help with the successful implementation of the lab, heads Siemens Healthineers' ITT global organization from Germany. Haider noted the benefits that students will see from this new partnership. "In addition to many new learning possibilities, the UofSC ITT lab's top participants will have the potential for receiving a variety of fellowships and internships with the Siemens Healthineers ITT lab global network," Haider said.
In conjunction with the opening of the ITT Lab, 20 participants from academic institutions such as South Carolina, Georgia Tech, Benedict College, and the University of Florida participated in a two-day "Interdisciplinary Innovations in Healthcare Workshop." There, the participants were challenged to identify a problem in the healthcare industry and then develop and present a real-world solution to that problem.
In just two days' time, these participants' ideas showed the possibilities of this new lab organized around innovation. Their ideas included an app for stroke detection and monitoring in real-time, an implant that holds patients' medical history, and a smart pill that treats obesity.
Lexington Medical Center will dedicate the largest hospital expansion in South Carolina history see more
Lexington Medical Center will dedicate the largest hospital expansion in South Carolina history on Thursday, according to a news release from the hospital.
The center will celebrate its new 545,000-square foot patient care tower, scheduled to open to patients March 26.
“Lexington Medical Center is integral to our community and woven into its fabric — today and forever,” Tod Augsburger, president and CEO of Lexington Medical Center said in the release. “The hospital’s mission is to meet the health needs of our community, and we’re committed to taking care of our families, friends and neighbors. We look forward to this new tower serving the people of the Midlands for many years to come.”
The new tower features patient rooms, eight operating rooms, educational space for staff and community members and enhanced dining options. It also includes six post-delivery rooms for patients in need of long-term monitoring, a mother/baby room for postpartum patients and a 20-bed special-care nursery with private rooms.
Six floors will accommodate medical, critical care and surgical patients. Lexington Medical Center staff performed more than 20,000 surgeries last year and deliver more than 3,300 babies annually, the release said. A mosaic of more than 4,000 of the 100,000 babies born at the hospital since its 1971 opening will be displayed inside the new tower.
The new tower will also add a 950-space parking garage and a central energy plant to support the tower. Read more about this milestone for South Carolina.